"Many patents filed have potential to be used in many other significant areas then contact lens as well!"
Many? There are 3 published US patents. Only 1 of the 3 could be applied outside of contact lenses.
Patents are irrelevant. All that matters is the ability to commercialize their IP, which to date, EPGL has been unable to do...
Commercialization does NOT require patent approval. If they had anyone seriously interested in any of the technology a deal would have already been made, IMO...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.